Horster Biotek Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-06-2024
- Paid Up Capital ₹ 0.10 M
as on 15-06-2024
- Company Age 14 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 15-06-2024
- Revenue -35.70%
(FY 2023)
- Profit -232.20%
(FY 2023)
- Ebitda -129.09%
(FY 2023)
- Net Worth -103.74%
(FY 2023)
- Total Assets -17.52%
(FY 2023)
About Horster Biotek
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 Cr.
Waman Jogi, Govindsai Kulkarni, Manish Tilala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP2010PTC024892
- Company No.
024892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Horster Biotek?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Waman Jogi  | Additional Director | 31-Jan-2024 | Current |
| Govindsai Kulkarni | Director | 01-Sep-2020 | Current |
| Manish Tilala | Director | 09-Mar-2015 | Current |
| Mehul Jhaveri | Director | 08-Dec-2010 | Current |
Financial Performance of Horster Biotek.
Horster Biotek Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.7% decrease. The company also saw a substantial fall in profitability, with a 232.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 103.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horster Biotek?
In 2022, Horster Biotek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Horster Life Science Private LimitedActive 11 years 2 monthsManish Tilala and Mehul Jhaveri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Feb 2017 | ₹2.50 Cr | Open |
How Many Employees Work at Horster Biotek?
Unlock and access historical data on people associated with Horster Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horster Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horster Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
